Myocardial Infarction in a Patient Treated with Anti-Interleukin-12 Biological Agent for Chronic Plaque Psoriasis

Vol. 26 No. 1, 2014 137 Received January 3, 2013, Revised March 5, 2013, Accepted for publication March 27, 2013 Corresponding author: Giuseppe Stinco, Institute of Dermatology, University of Udine, Ospedale “San Michele” di Gemona piazza Rodolone 1, Gemona del Friuli (Udine) 33013, Italy. Tel: 39-0432-989378, Fax: 39-0432-989209, E-mail: [email protected] This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. loricrin, and filaggrin in cultured sebocytes. In conclusion, cultured sebocytes showed little expression of keratinocyte differentiation markers. Weak physical barrier in the sebaceous gland may cause much better transfollicular drug delivery.